These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Accumulation of apoptosis-insensitive human bone marrow-mesenchymal stromal cells after long-term expansion. Jeong SG; Cho GW Cell Biochem Funct; 2016 Jul; 34(5):310-6. PubMed ID: 27212655 [TBL] [Abstract][Full Text] [Related]
65. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells. Cheng KY; Hao M Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743 [TBL] [Abstract][Full Text] [Related]
66. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia. Li J; Xue L; Hao H; Han Y; Yang J; Luo J Oncol Rep; 2012 Feb; 27(2):461-6. PubMed ID: 21993902 [TBL] [Abstract][Full Text] [Related]
67. Downregulation of Melanoma Cell Adhesion Molecule (MCAM/CD146) Accelerates Cellular Senescence in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells. Jin HJ; Kwon JH; Kim M; Bae YK; Choi SJ; Oh W; Yang YS; Jeon HB Stem Cells Transl Med; 2016 Apr; 5(4):427-39. PubMed ID: 26941359 [TBL] [Abstract][Full Text] [Related]
69. An in vitro expansion score for tissue-engineering applications with human bone marrow-derived mesenchymal stem cells. Bertolo A; Mehr M; Janner-Jametti T; Graumann U; Aebli N; Baur M; Ferguson SJ; Stoyanov JV J Tissue Eng Regen Med; 2016 Feb; 10(2):149-61. PubMed ID: 23576360 [TBL] [Abstract][Full Text] [Related]
71. Hormetic effect of low doses of rapamycin triggers anti-aging cascades in WRL-68 cells by modulating an mTOR-mitochondria cross-talk. Mahalakshmi R; Priyanga J; Bhakta-Guha D; Guha G Mol Biol Rep; 2022 Jan; 49(1):463-476. PubMed ID: 34739690 [TBL] [Abstract][Full Text] [Related]
72. Short exposure to cold atmospheric plasma induces senescence in human skin fibroblasts and adipose mesenchymal stromal cells. Bourdens M; Jeanson Y; Taurand M; Juin N; Carrière A; Clément F; Casteilla L; Bulteau AL; Planat-Bénard V Sci Rep; 2019 Jun; 9(1):8671. PubMed ID: 31209329 [TBL] [Abstract][Full Text] [Related]
73. CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells. Psaroudis RT; Singh U; Lora M; Jeon P; Boursiquot A; Stochaj U; Langlais D; Colmegna I Stem Cell Res Ther; 2022 Jul; 13(1):358. PubMed ID: 35883188 [TBL] [Abstract][Full Text] [Related]
74. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924 [TBL] [Abstract][Full Text] [Related]
75. Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop. Gao L; Bird AK; Meednu N; Dauenhauer K; Liesveld J; Anolik J; Looney RJ Arthritis Rheumatol; 2017 Aug; 69(8):1623-1635. PubMed ID: 28471483 [TBL] [Abstract][Full Text] [Related]
76. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation. Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549 [TBL] [Abstract][Full Text] [Related]
77. Survival/Adaptation of Bone Marrow-Derived Mesenchymal Stem Cells After Long-Term Starvation Through Selective Processes. Ferro F; Spelat R; Shaw G; Duffy N; Islam MN; O'Shea PM; O'Toole D; Howard L; Murphy JM Stem Cells; 2019 Jun; 37(6):813-827. PubMed ID: 30835892 [TBL] [Abstract][Full Text] [Related]
78. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Leontieva OV; Blagosklonny MV Aging (Albany NY); 2010 Dec; 2(12):924-35. PubMed ID: 21212465 [TBL] [Abstract][Full Text] [Related]
79. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. Hoerning A; Wilde B; Wang J; Tebbe B; Jing L; Wang X; Jian F; Zhu J; Dolff S; Kribben A; Hoyer PF; Witzke O Transplantation; 2015 Jan; 99(1):210-9. PubMed ID: 25099702 [TBL] [Abstract][Full Text] [Related]
80. Cell senescence, rapamycin and hyperfunction theory of aging. Blagosklonny MV Cell Cycle; 2022 Jul; 21(14):1456-1467. PubMed ID: 35358003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]